• 1
    Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340: 913.
  • 2
    Sibai BM. Thrombophilias and adverse outcomes of pregnancy—what should a clinician do? N Engl J Med 1999;340: 5051.
  • 3
    Grandone E, Margaglione M, Colaizzo D, et al. Factor V leiden C>T MTFHR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997;771052771054.
  • 4
    Martinelli I, Taioli E, Cetin I, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000;343: 10151018.
  • 5
    Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348: 913916.
  • 6
    Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999;82: 69.
  • 7
    Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976;126: 555564.
  • 8
    Miller SA, Polskey HF. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res 1988;18: 1215.
  • 9
    Ridker PM, Hennekens CH, Lindapaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332(14):912917.
  • 10
    Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10: 111113.
  • 11
    Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88(10):36983703.
  • 12
    Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996;175: 902905.
  • 13
    Lindoff C, Ingemarsson I, Matinson G, Segelmark M, Thysell H, Astedt B. Preeclampsia is associated with a reduced response to activated protein C. Am J Obstet Gynecol 1997;176: 457460.
  • 14
    Grandone E, Margaglione M, Colaizzo D, et al. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997;77: 10521054.
  • 15
    Nagy B, Toth T, Rigo Jr J, Karadi I, Romics L, Papp Z. Detection of factor V leiden mutation in severe pre-eclamptic Hungarian women. Clin Genet 1998;53: 478481.
  • 16
    Dekker GA, de Vries JIP, Doelitzsch PM, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1996;173: 10421048.
  • 17
    Wiener-Megnagi Z, Ben-Shlomo I, Goldberg Y, Shalev E. Resistance to activated protein C and the leiden mutation: high prevalence in patients with abruptio placentae. Am J Obstet Gynecol 1998;179: 15651567.
  • 18
    Arias F, Romero R, Joist H, Kraus FT. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med 1998;7: 277286.
  • 19
    Dizon-Townson DS, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of the factor V leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177: 402405.
  • 20
    Vern TZ, Alles AJ, Kowal-Vern A, Longtine J, Roberts DJ. Frequency of factor V (Leiden) and prothrombin G20210A in placentas and their relationship with placental lesions. Hum Pathol 2000;31: 10361043.
  • 21
    Mousa HA, Alfirevici Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod 2000;15: 18301833.
  • 22
    Many A, Elad R, Yaron Y, Eldor A, Lessing JB, Kuperminc MJ. Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol 2002;99: 684687.
  • 23
    Verspyck E, Le CD, Goffinet F, Tron F, Marpeau L, Borg JY. Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants. Br J Obstet Gynaecol 2002;109: 2833.
  • 24
    Infant-Rivard C, Rivard GE, Yotov WV, et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002;347: 1925.